SARCOMA FOUNDATION OF AMERICA ANNOUNCES 2026 RESEARCH GRANT AWARDS

Sarcoma Foundation of America, the largest private funder of research in the sarcoma community, announced the recipients of its 2026 Research Grant Program.

BETHESDA, MD, UNITED STATES, October 14, 2026 /EINPresswire.com/ -- The Sarcoma Foundation of America (SFA), an organization dedicated to advancing sarcoma research and awareness and the largest private funder of research in the sarcoma community, has announced the recipients of its 2026 Research Grant Program. SFA has awarded eight research grants totaling almost $600,000 to scientists pursuing innovative research to better understand sarcoma, develop new treatments, and ultimately find a cure for these rare cancers.

Eight research grants, each providing up to $75,000, have been awarded to researchers dedicated to advancing the understanding and treatment of sarcoma, cancers that develop in the body’s soft tissue and bone. All proposals undergo peer review by members of SFA’s Medical Advisory Board, who select the most promising research with the potential to advance progress toward a cure.

Since its inception, SFA has invested more than $27 million in sarcoma research through its research grant program and collaborative research initiatives, helping accelerate discoveries and support the next generation of sarcoma research. More information on SFA’s research efforts can be found at https://www.curesarcoma.org/sarcoma-research/research-grants-policy/

Sarcoma Foundation of America Research Award 

Padmini Bisoyi, PhD, MSc

The Regents of the University of California, San Francisco

“WEE1/PKMYT1 Dual Targeting in CIC::DUX4 Sarcoma”

---

Sarcoma Foundation of America Research Award 

Ignazio Caruana,PhD

University Hospital of Würzburg (Universitätsklinikum Würzburg)

“Translation of Autophagy-Reprogrammed B7-H3 CAR T”

---

Sarcoma Foundation of America Research Award 

Ping Chi, MD, PhD

Memorial Sloan Kettering Cancer Center

“Understanding and targeting MYC in angiosarcoma”

---

Sarcoma Foundation of America Research Award 

Yuan Gao, PhD

Case Western Reserve University School of Medicine

“Lipid-Sensing ETV6 Vulnerability in Ewing Sarcoma”

---

Sarcoma Foundation of America Research Award 

David Kirsch, MD, PhD

University Health Network

“Optimizing CDK4/6 blockade in epithelioid sarcoma”

---

Sarcoma Foundation of America Research Award 

Shannon Oda, PhD

Seattle Children’s Hospital

“Developing multipronged cell therapy for RMS”

---

Sarcoma Foundation of America Research Award 

Ian Roundtree, MD, PhD

Massachusetts General Hospital

“An Implantable Microdevice in Soft Tissue Sarcoma”

---

Sarcoma Foundation of America Research Award 

Haoqiang Ying, PhD

The University of Texas MD Anderson Cancer Center

“Targeting ATRX mutation in UPS”

##

About the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, is an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of sarcoma patients. For more information, please visit www.curesarcoma.org.

About Sarcoma
Sarcoma is a rare cancer in adults (1% of all adult cancers) but more common in children (15-20% of childhood cancers). At any one time, 236,000 patients and their families are impacted by sarcoma. Every year, more than 18,000 new cases are diagnosed, and more than 7,600 people die from the disease.

David Koetke
Sarcoma Foundation of America
Dkoetke@curesarcoma.org
Visit us on social media:
Instagram
Facebook
X
Other